[Arg8]Vasopressin TFA – (129979-57-3)

Argipressin acetate, Argipressin monoacetate, 129979-57-3, 83968-48-3, UNII-HF9374N68K, DTXSID2046597, HF9374N68K, EINECS 281-528-0, Vasopressin, 8-l-arginine-, monoacetate (salt), [Arg 8]-Vasopressin Acetate, DTXCID0026597, ARGIPRESSIN ACETATE [WHO-DD], acetic acid (2S)-1-[(4R, 7S, 10S, 13S, 16S, 19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6, 9, 12, 15, 18-pentaoxo-1, 2-dithia-5, 8, 11, 14, 17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide, AVP, [Arg8]-Vasopressin acetate salt, NCGC00166306-01, Argipressin (acetate), Argipressin acetate (113-79-1(free base)), MLS000517260, VASOPRESSIN MONOACETATE, CHEMBL2360839, ZHFGXNMADRRGQP-HPILINOVSA-N, GLXC-25924, Tox21_112403, MFCD00133939, Vasopressin, 8-L-arginine-, monoacetate, Vasopressin, 8-L-arginine-, monoacetate, DA-50687, FV138119, SMR000127423, CAS-129979-57-3, V0159, D92791, SBI-0654109.0001, [Arg8]-Vasopressin acetate salt, >=95% (HPLC), H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 AcOH, Q27279900, (2S)-2-{[(2S)-1-[(4R, 7S, 10S, 13S, 16S, 19R)-19-AMINO-13-BENZYL-10-(2-CARBAMOYLETHYL)-7-(CARBAMOYLMETHYL)-16-[(4-HYDROXYPHENYL)METHYL]-6, 9, 12, 15, 18-PENTAOXO-1, 2-DITHIA-5, 8, 11, 14, 17-PENTAAZACYCLOICOSANE-4-CARBONYL]PYRROLIDIN-2-YL]FORMAMIDO}-5-CARBAMIMIDAMIDO-N-(CARBAMOYLMETHYL)PENTANAMIDE ACETIC ACID, (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-5-((diaminomethylene)amino)-1-oxopentan-2-yl)-1-((4R, 7S, 10S, 13S, 16S, 19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6, 9, 12, 15, 18-pentaoxo-1, 2-dithia-5, 8, 11, 14, 17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide acetate, 281-528-0